Navigation Links
Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month
Date:10/19/2007

Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain

Scans, Oct 26 & 27, as Part of Clinical Study.

CHICAGO, Oct. 19 /PRNewswire/ --

What: Women diagnosed with HER-2 positive Stage III or Stage IV

breast cancer are eligible to receive an MRI of the brain

at no charge as part of a clinical trial. HER2 is a breast

cancer that tests positive for a protein called human

epidermal growth factor receptor-2 (HER2), which promotes

the growth of cancer cells. Studies have shown that in as

many as 30 percent of breast cancer patients have a

metastasis in the brain. As part of the screening

protocol, participants will undergo a MRI of the brain. The

cost of the MRI is covered by the clinical trial.

Who: Patients who qualify must have an initial primary diagnosis

of high risk and/or HER-2 positive breast cancer. They

must be at least 18 years and should not participate if

they are pregnant.

When: Friday, October 26th, 1 p.m. to 9 p.m.

Saturday, October 27th, 8 a.m. to 5 p.m.

Where: Neurologic and Orthopedic Institute of Chicago

4501 N. Winchester, Chicago

Cost: The brain MRI is free of charge to the patient.

Background: The Chicago Institute of Neurosurgery and Neuroresearch

(CINN) Medical Group will use information from the

screening to determine the potentialbenefit(s) of screening

for brain metastases in patients with advanced breast

cancer.

Study Selection & Enrollment Criteria

Women must be within three to twenty-four months of first

metastases of Stage IV diagnosis or within 12 to 24 months

of initial diagnosis of HER-2 positive Stage III disease.

They must sign a written consent form approved by the CINN

Institutional Review Board (IRB).

Exclusion criteria

Patients with a prior diagnosis of brain metastases or who

are unable to be safely exposed to MRIs. Most common

exclusions include, but are not limited to, pacemakers,

implanted defibrillators, neurostimulators, aneurysm clips,

cochlear devices, or any other institution

contraindications. Women who are pregnant.

CONTACT: Sandi Davis of Chicago Institute of Neurosurgery and Neuroresearch, 773-250-0425, http://www.cinn.org

Media Contact: Lisa Stafford, P.S. Communications, 630-986-8749, Cell: 630-212-1226, Email: lisa@pscommunicationsinc.com


'/>"/>
SOURCE Chicago Institute of Neurosurgery and Neuroresearch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
4. “Brain fingerprinting”- The new lie detectr
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Two doctors suspended for wrong brain surgery
7. The brain loves a surprise
8. Virus Combats Brain Tumour
9. Increase in sugar...decrease in brain function!!!
10. Alcohol shrinks brain
11. Roller coaster takes brain for a big ride!!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... ... the National Association of Music Merchants (NAMM) winter trade show, Booth #2876, at ... Etymotic’s ER•4® has long been the gold standard for high-definition, in-ear earphones. This ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Palm Desert, is opening a new office in San Clemente, California this month. ... (dTMS) in Southern California, successfully treating individuals struggling with major depression. Depression impacts ...
(Date:1/17/2017)... ... 2017 , ... Medic-CE , a Career Step company ... released four new continuing education courses as part of its Code3 CME Virtual ... classroom and meet the requirements of the National Continued Competency Program (NCCP), the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New ... eye care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment ... Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... with Sigfox in the U.S.A. to offer Internet of Things (IoT) ... offerings on large-scale environmental sensor deployments such as monitoring solutions used to detect ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Interpace Diagnostics Group, Inc., (NASDAQ: IDXG ), a ... pathology services for evaluating risks of cancer, announced today ... 2017 from the NASDAQ Listing Qualifications notifying the Company ... the NASDAQ Stock Market to maintain a minimum closing ... letter noted that for the last 10 days from ...
(Date:1/17/2017)... 17, 2017 Tempus, a technology company ... University Hospitals Seidman Cancer Center have joined together ... data, advanced molecular analysis and clinical decision support ... healthcare providers. As part of ... transcriptomic sequencing and analysis for ovarian and triple ...
(Date:1/17/2017)... , Jan. 17, 2017  CSSi, the global ... the clinical research industry, will exhibit at the 8 ... Executives (SCOPE 2017), taking place from Tuesday, January 24 ... Miami in Miami, FL. ... proprietary technology platform, SmartStudy™ EMR, which provides a revolutionary ...
Breaking Medicine Technology: